NCT05596461 is a NA clinical trial of Transcranial magnetic stimulation in Affective Disorder, sponsored by First Affiliated Hospital of Zhejiang University.

Who is sponsoring NCT05596461?

NCT05596461 is sponsored by First Affiliated Hospital of Zhejiang University.

What drugs are being tested in NCT05596461?

Interventions in NCT05596461: Transcranial magnetic stimulation, Transcranial direct current stimulation.

What condition does NCT05596461 study?

NCT05596461 studies Affective Disorder.

Is NCT05596461 still recruiting?

NCT05596461 is currently status unknown. Last updated 10 March 2023.

Last reviewed 2023-03-10 · How we verify

NCT05596461

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

New Techniques for Diagnosis and Treatment of Cognitive Impairment in Affective Disorder

Status unknown NA Last updated 10 March 2023

What this trial tests

NA trial testing Transcranial magnetic stimulation in Affective Disorder in 90 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
31 December 2023

1 October 2024

Quick facts

Lead sponsor	First Affiliated Hospital of Zhejiang University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	90
Start date	1 January 2022
Primary completion	31 December 2023
Estimated completion	1 October 2024
Sites	1 location across China

Drugs / interventions tested

Transcranial magnetic stimulation — full drug profile →
Transcranial direct current stimulation

Conditions studied

Affective Disorder — all drugs for Affective Disorder →

Sponsor

First Affiliated Hospital of Zhejiang University

Who can join

Adults 16 to 65, any sex, with Affective Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to explore the pathological mechanism of cognitive impairment in patients with affective disorder based on brain gut axis research, preliminarily verify the clinical efficacy of new neural regulation technology on cognitive impairment, and establish an evaluation model to predict the efficacy of physical therapy for affective disorder.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cognitive Remediation in Patients With Bipolar Disorder: A Randomized Trial by Sequential tDCS and Navigated rTMS Targeting the Primary Visual Cortex.
Zhou H, Wang M, Xu T, Zhang X, et al · · 2024 · cited 5× · PMID 39703101 · DOI 10.1111/cns.70179

Verify or expand the search:

Other trials of Transcranial magnetic stimulation

Trials testing the same drug.

NCT07167940 — Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days · Phase 3 · not yet recruiting
NCT07035119 — Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain · Phase 1, PHASE2 · not yet recruiting
NCT07369960 — Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Glo · NA · recruiting
NCT07085910 — Hebbian-Type Associative Stimulation in Stroke Rehabilitation · NA · not yet recruiting
NCT06376734 — Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness · Phase 2 · recruiting

Other recruiting trials for Affective Disorder

Currently open trials in the same condition.

NCT06594263 — Validation of the French Version of the Perinatal Assessment of Paternal Affectivity (PAPA) · recruiting

Other First Affiliated Hospital of Zhejiang University trials

Trials by the same sponsor.

NCT07537192 — Inulin-Spirulina Co-intervention for Insomnia Disorder · NA · not yet recruiting
NCT07510867 — 18F-FAPI PET/CT and MRI in Gastric Cancer · not yet recruiting
NCT07589647 — Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic D · NA · recruiting
NCT07525765 — AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer · recruiting
NCT07468162 — Characteristic Electroencephalogram of General Anesthesia · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05596461 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Zhejiang University
Last refreshed: 10 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05596461.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing